Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp, on Wednesday announced launch of nasal spray to treat adult Covid-19 ...
Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark has been the ...
Republic Business on MSN3mon
Glenmark Pharmaceuticals Issues Product Recalls in USThe first recall affects 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray. Glenmark ...
Glenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray for the treatment of seasonal allergic rhinitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback